EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aker BioMarine ASA's enterprise value is kr10,592 Mil.
Aker BioMarine ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr621 Mil. Therefore, Aker BioMarine ASA's EV-to-EBITDA for today is 17.04.
The historical rank and industry rank for Aker BioMarine ASA's EV-to-EBITDA or its related term are showing as below:
OSL:AKBM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.18 Med: 13.41 Max: 24
Current: 17.05
During the past 12 years, the highest EV-to-EBITDA of Aker BioMarine ASA was 24.00. The lowest was 8.18. And the median was 13.41.
OSL:AKBM's EV-to-EBITDA is ranked worse than 69.9% of 1538
companies
in the Consumer Packaged Goods industry
Industry Median: 10.86
vs OSL:AKBM: 17.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Aker BioMarine ASA EV-to-EBITDA Historical Data
The historical data trend for Aker BioMarine ASA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aker BioMarine ASA's EV-to-EBITDA
For the Packaged Foods subindustry, Aker BioMarine ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's EV-to-EBITDA falls into.
Aker BioMarine ASA's current Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr621 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Aker BioMarine ASA's PE Ratio for today is calculated as:
Aker BioMarine ASA's share price for today is kr74.80.
Aker BioMarine ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.517.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Aker BioMarine ASA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Aker BioMarine ASA (OSL:AKBM) Business Description
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSL:AKBM has been successfully added to your 